Proteomic Insights into Salt-Stress Tolerance in Zygosaccharomyces rouxii Revealed by Data-Independent Acquisition Mass Spectrometry
Journal of Proteome Research · 07.08.2026 · 25 (8) · 4229-4236
DOI: 10.1021/acs.jproteome.6c00219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 27.07.2026. Verfasst von Dingkang Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Examination, Honghui Hospital, Xi'an Jiaotong University, Xi'an710054, China. Hauptthemen laut MEDLINE: Zygosaccharomyces, Proteomics, Proteome, Salt Stress. Die Arbeit nennt 32 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National College Students Innovation and Entrepreneurship Training Program, Natural Science Basic Research Program of Shaanxi Province.
Abstract (Originalsprache)
Zygosaccharomyces rouxii is a halotolerant yeast commonly associated with high-salt fermentations, although its proteome-level adaptation mechanisms are little understood. DIA-based quantitative proteomics was used to characterize the salt-stress responses of Z. rouxii CGMCC 3791 grown at 0, 60, and 120 g/L NaCl. Principal component analysis demonstrated high repeatability and a unique proteome state at 120 g/L of NaCl. Differential analysis revealed 251 differentially expressed proteins (DEPs) (148 up, 103 down) at 60 g/L and 798 DEPs (549 up, 249 down) at 120 g/L, demonstrating significant concentration-dependent remodeling. Under severe stress, GO and KEGG enrichment consistently revealed the reinforcement of central carbon and energy metabolism, peroxisome-associated fatty acid turnover, oxidoreductase/redox activities, and translation and nucleotide metabolic pathways. Heatmap clustering and PPI networks revealed additional tightly coordinated modules that connect bioenergetics, redox regulation, and the translational capacity. These findings provide a proteome-scale framework for understanding halotolerance in Z. rouxii and guidance for future high-salt fermentation engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Functional Examination, Honghui Hospital, Xi'an Jiaotong University, Xi'an710054, China.
- Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an710061, China.
- Department of Pharmacology, Yong Loo Lin School of Medicine National University of Singapore, Singapore117600, Singapore.
- Nuclear Industry 215 Hospital of Shaanxi Province, Xianyang712099, China.
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu610041, China.
- School of Physical Education, Xi'an Jiaotong University, Xi'an710049, China.
ORCID-Profile: Dingkang Wang
Förderung
- China Postdoctoral Science Foundation
- National College Students Innovation and Entrepreneurship Training Program
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Wang, D., Wang, L., Xiao, Y., Su, C., Kang, Y., Dong, R., Gou, W., Yu, H., Chen, H., & Zhang, Y. (2026). Proteomic Insights into Salt-Stress Tolerance in Zygosaccharomyces rouxii Revealed by Data-Independent Acquisition Mass Spectrometry. Journal of Proteome Research, 25(8), 4229-4236. https://doi.org/10.1021/acs.jproteome.6c00219
Vancouver
Wang D, Wang L, Xiao Y, Su C, Kang Y, Dong R, et al. Proteomic Insights into Salt-Stress Tolerance in Zygosaccharomyces rouxii Revealed by Data-Independent Acquisition Mass Spectrometry. Journal of Proteome Research. 2026;25(8):4229-4236. doi:10.1021/acs.jproteome.6c00219
BibTeX
@article{Wang2026,
author = {Wang, Dingkang and Wang, Li and Xiao, Yue and Su, Chengmei and Kang, Yiting and Dong, Rui and Gou, Wanglong and Yu, Hongfei and Chen, Hong and Zhang, Yongjie},
title = {Proteomic Insights into Salt-Stress Tolerance in Zygosaccharomyces rouxii Revealed by Data-Independent Acquisition Mass Spectrometry},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {8},
pages = {4229--4236},
doi = {10.1021/acs.jproteome.6c00219}
}
EUVIMED